AdipoPharma Starts Phase 1b PATAS Trial in Type 2 Diabetes
AdipoPharma has started a Phase 1b clinical study of PATAS in patients with type 2 diabetes.
Related stories
China Risun Seeks Approval for RMB 506.94 Million Injection
China Risun is seeking shareholder approval for an RMB 506.94 million injection into Xiangfu New Energy.
M impact | EQUITY | Oct 29, 2026, 11:57 AM UTC
Sirius XM Q3 2026 Earnings Call Begins
Sirius XM's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 11:57 AM UTC
EMCOR 3Q-End Remaining Performance Obligations Rise 47% to $18.57B
M impact | EQUITY | Oct 29, 2026, 11:57 AM UTC
EMCOR Increases Share-Repurchase Program by $500 Million
M impact | EQUITY | Oct 29, 2026, 11:56 AM UTC
National Hotels Q3 Hotel Services Revenue 1.1 Million Dinars
National Hotels reported Q3 hotel services revenue of 1.1 million dinars.
M impact | EQUITY | Oct 29, 2026, 11:55 AM UTC
HSBC Announces Dividend of R$ 0.6379187050 per Unit
HSBC Holdings announced a dividend of R$ 0.6379187050 per unit.
M impact | EQUITY | Oct 29, 2026, 11:55 AM UTC